Ledger.Open graph →
SEC Form D · Amendment · filed June 7, 2022

Mytide Therapeutics, Inc

Offering
$7.1M
Sold
$7.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Dale Thomas · Boston, MAExec · Director · PromoterJason Norris · Boston, MAExec · Director · PromoterErrik Anderson · Boston, MADirectorRichard H. Ruffer · Grand Cayman, Cayman IslandsExec · Director · PromoterMaria B. Zondervan · Apopka, FLDirectorHock Lau · Singapore, U0Exec · Director · PromoterCapula Investment US LP · New York, NYExec · Director · PromoterDah Hui Lau · Singapore, U0Exec · Director · PromoterMatthew Chapdelaine · Mt. Pleasant, SCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗